Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

19 Jan 2024 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated January 19, 2024 titled ‘Zydus and Synthon enter into an exclusive licensing and supply agreement for Palbociclib Tablets (generic version of IBRANCE®) for the US market. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1896.00
Dr. Reddys Labs. 1376.00
Cipla 1417.00
Lupin 2021.00
Zydus Lifesciences 1190.10
View more..